EARNINGS BEAT: A big tax break helped biotech giant Amgen post better-than-expected quarterly earnings, despite disappointing drug sales.
SALES MISS: Revenue rose 5 percent to $4.24 billion, but missed analyst expectations of $4.37 billion.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.